RM-9 prostate tumors expressed both G-CSF and GM-CSF (Figures 6C, D, respectively); however, tumor expression of poor survival marker, G-CSF was ten-fold higher than GM-CSF. The gene discussed is CSF2; the disease is neoplasm.